Jinjuan Wang , Menghai Wu , Subash C.B. Gopinath , Abubakr M. Idris , Xi Zhang
{"title":"Identifying fibril formation on interdigitated parallel microelectrodes for diagnosing Parkinson's disease","authors":"Jinjuan Wang , Menghai Wu , Subash C.B. Gopinath , Abubakr M. Idris , Xi Zhang","doi":"10.1016/j.bej.2025.109831","DOIUrl":null,"url":null,"abstract":"<div><div>Parkinson’s Disease (PD), commonly seen in adults over the age of 65, is the second most common neurodegenerative disorder. Researchers are working towards developing a highly sensitive biosensor for diagnosing PD. Diamond-gold nanomaterials hybrid on interdigitated parallel microelectrode (IDME) biosensor is introduced for diagnosing PD. Alpha-synuclein contributes to the progression of PD, it was used as a target to diagnose PD, and aptamer was immobilized as a capture molecule. For higher aptamer immobilization, IDME was modified by diamond nanomaterial through 1,1′-Carbonyldiimidazole linker and then aptamer (with or without gold nanoparticle conjugated) was attached on the diamond by using an amine-linker. This aptamer immobilized surfaces detect the alpha-synuclein by aptamer-antibody sandwich and lowers the detection limit to 1 aM [y = 1.5679x − 1.7834; R² = 0.9904] in the buffer sample and 10 aM in an artificial cerebrospinal fluid on a linear regression from 1 aM until 1 nM. In addition, control performances with DJ-1, PARK-1, and complementary anti-alpha-synuclein aptamer failed to increase the current responses confirm the specific detection of alpha-synuclein. This diamond modified IDME quantifies the alpha-synuclein at its lower level and helps to diagnose PD.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"222 ","pages":"Article 109831"},"PeriodicalIF":3.7000,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25002050","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Parkinson’s Disease (PD), commonly seen in adults over the age of 65, is the second most common neurodegenerative disorder. Researchers are working towards developing a highly sensitive biosensor for diagnosing PD. Diamond-gold nanomaterials hybrid on interdigitated parallel microelectrode (IDME) biosensor is introduced for diagnosing PD. Alpha-synuclein contributes to the progression of PD, it was used as a target to diagnose PD, and aptamer was immobilized as a capture molecule. For higher aptamer immobilization, IDME was modified by diamond nanomaterial through 1,1′-Carbonyldiimidazole linker and then aptamer (with or without gold nanoparticle conjugated) was attached on the diamond by using an amine-linker. This aptamer immobilized surfaces detect the alpha-synuclein by aptamer-antibody sandwich and lowers the detection limit to 1 aM [y = 1.5679x − 1.7834; R² = 0.9904] in the buffer sample and 10 aM in an artificial cerebrospinal fluid on a linear regression from 1 aM until 1 nM. In addition, control performances with DJ-1, PARK-1, and complementary anti-alpha-synuclein aptamer failed to increase the current responses confirm the specific detection of alpha-synuclein. This diamond modified IDME quantifies the alpha-synuclein at its lower level and helps to diagnose PD.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.